145 related articles for article (PubMed ID: 6766663)
1. Effects of therapy on carcinoembryonic antigen activity in the urines of patients with cancer of the bladder.
James K; Alroy J; Miller AW; Flanagan M
Am J Clin Pathol; 1980 Feb; 73(2):250-3. PubMed ID: 6766663
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemically demonstrated expression of epithelial membrane antigen and carcinoembryonic antigen by exfoliated urinary cells in patients with bladder cancer.
Tanaka K; Takashi M; Miyake K; Koshikawa T
Urol Int; 1994; 52(3):140-4. PubMed ID: 8203052
[TBL] [Abstract][Full Text] [Related]
3. Urinary carcinoembryogenic antigen (CEA) in the diagnosis and follow-up of bladder carcinoma.
Tailly G; Cornelissen M; Vereecken RL; Verduyn H; Devos P; De Roo M
Br J Urol; 1983 Oct; 55(5):501-7. PubMed ID: 6626896
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathological study of urinary bladder tumors. Clinical evaluation of immunohistochemistry in urine cytology].
Nagata Y; Kinoshita H; Kawamura N; Sasadaira S
Hinyokika Kiyo; 1985 Nov; 31(11):1931-7. PubMed ID: 4091136
[TBL] [Abstract][Full Text] [Related]
5. Urine carcinoembryonic antigen determination in urinary bladder bilharziasis predicts carcinoma in patients with premalignant lesions: observation of 43 cases in Egypt.
Saied GM; El-Metenawy WH; Elwan MS; Dessouki NR
Tanzan Health Res Bull; 2006 Sep; 8(3):122-7. PubMed ID: 18254501
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of urinary CEA measurement as a screening test of bladder cancer (author's transl)].
Oshiumi Y; Yagi H; Nishitani H; Yamawaki H; Nakayama C; Kamoi I; Matsuura K; Momose S
Radioisotopes; 1979 Jun; 28(6):367-70. PubMed ID: 531259
[TBL] [Abstract][Full Text] [Related]
7. [Coadjuvant action of chemotherapy and immunotherapy in the carcinoma of the bladder].
Rodrigues-Netto Júnior N; Napoli F; Lemos GC
Rev Paul Med; 1979; 94(3-4):51-3. PubMed ID: 121486
[No Abstract] [Full Text] [Related]
8. Carcino-embryonic antigen activity in urine of patients with bladder carcinoma. Clinical evaluation of carcino-embryonic antigen. II.
Korsten CB; Persijn JP; Renaud J; Houtzager-Boelens CA
J Clin Chem Clin Biochem; 1976 Aug; 14(8):389-93. PubMed ID: 965892
[TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen and bladder carcinoma.
Ionescu G; Romas NA; Ionascu L; Bennett S; Tannenbaum M; Veeneman RJ; Lattimer JK
J Urol; 1976 Jan; 115(1):46-8. PubMed ID: 1107601
[TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic-like antigen in the urine of patients with carcinoma of the bladder and normal controls.
Guinan P; Ablin RJ; Sadoughi N; Bush IM
J Surg Oncol; 1974; 6(2):127-31. PubMed ID: 4822898
[No Abstract] [Full Text] [Related]
11. Urinary carcinoembryonic antigen (CEA)-like molecules and urothelial malignancy: a clinical appraisal.
Coombers GB; Hall RR; Laurence JR; Neville AM
Br J Cancer; 1975 Feb; 31(2):135-42. PubMed ID: 1164465
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of urinary carcino-embryonic antigen estimations during the follow-up of patients with bladder carcinoma or previous bladder carcinoma. Clinical evaluation of carcino-embryonic antigen, III.
Persijn JP; Korsten CB; Batterman JJ; Tierie AH; Renaud J
J Clin Chem Clin Biochem; 1976 Aug; 14(8):395-9. PubMed ID: 965893
[TBL] [Abstract][Full Text] [Related]
13. Urinary evaluation of tumor-associated antigens in urothelial bladder tumors.
Piana P; Casetta G; Cavallini A; Piantino P; Tizzani A
Prog Clin Biol Res; 1991; 370():179-84. PubMed ID: 1924448
[No Abstract] [Full Text] [Related]
14. Measurement of urinary CEA-like substance. An aid in management of patients with bladder carcinoma.
Wahren B; Edsmyr F; Zimmerman R
Cancer; 1975 Oct; 36(4):1490-5. PubMed ID: 1175143
[TBL] [Abstract][Full Text] [Related]
15. Treatment of superficial carcinoma of the bladder.
Paulson DF
Prog Clin Biol Res; 1984; 162B():193-209. PubMed ID: 6209720
[No Abstract] [Full Text] [Related]
16. Bladder carcinoma treated by irradiation and surgery: interval report.
Deweerd JH; Colby MY
Trans Am Assoc Genitourin Surg; 1972; 64():74-8. PubMed ID: 4654525
[No Abstract] [Full Text] [Related]
17. Determination of carcinoembryonic antigen in tissue, serum and urine in patients with transitional cell carcinoma of the urinary bladder.
Jakse G; Rauschmeier H; Rosmanith P; Hofstädter F
Urol Int; 1983; 38(3):121-5. PubMed ID: 6868210
[TBL] [Abstract][Full Text] [Related]
18. Selection of treatment for muscle infiltrating transitional cell bladder cancer.
Whitmore WF
Arch Esp Urol; 1990; 43 Suppl 2():219-22. PubMed ID: 2096783
[TBL] [Abstract][Full Text] [Related]
19. [Carcinoembryonic antigen in tumor tissue and urine in cases with primary bladder cancer--a study by immunogold-silver staining and radioimmunoassay].
Kawano S
Nihon Hinyokika Gakkai Zasshi; 1988 Mar; 79(3):469-74. PubMed ID: 2464713
[No Abstract] [Full Text] [Related]
20. Management of transitional cell carcinoma of the bladder.
Murshidi MS
Arch Esp Urol; 1989 Mar; 42(2):172-5. PubMed ID: 2735783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
